Allison and Honjo's research focused on the body's immune system and how it can be harnessed to combat cancer. They identified proteins that serve as brakes on the immune system, namely CTLA-4 and PD-1. By developing therapies that block these proteins, they were able to enhance the immune response against cancer cells. This approach has led to remarkable success in treating cancers that were previously considered untreatable.
